THIẾU MÁU TAN MÁU MIỄN DỊCH DO THUỐC - NHÂN 4 TRƯỜNG HỢP TAN MÁU MIỄN DỊCH DO CEFTRIAXIONE

Abstract

Drug-induced immune hemolytic anemia (DIIHA) is a complex condition in which red blood cells are destroyed by an immune reaction to a specific drug. Although relatively rare, DIIHA can cause serious consequences, ranging from fatigue and weakness to life-threatening complications. During treatment, especially in critically ill patients, many types of drugs are used, and if drug-induced hemolytic anemia occurs, the patient will become even more seriously ill. Early detection of hemolytic conditions is very important, and screening for risk drugs must be carried out immediately. Stopping the drug causing hemolytic anemia is very important and it is main  role in treatment. Failure to detect the cause of hemilytic due to drug can affect the patient's life. We have detected 4 cases of ceftriaxone-induced immune hemolytic anemia in time at the National Children's Hospital, with severe patients showing signs of shock. The patients were transfused and stopped taking ceftriaxone immediately, so their condition quickly stabilized and they overcame the severe condition.